A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Quanterix Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 27,000 shares of QTRX stock, worth $381,780. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,000
Previous 11,100 143.24%
Holding current value
$381,780
Previous $261,000 36.4%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.26 - $23.78 $2.12 Million - $4.11 Million
172,962 Added 279.92%
234,751 $3.1 Million
Q1 2024

May 15, 2024

BUY
$21.9 - $28.28 $703,975 - $909,060
32,145 Added 108.44%
61,789 $1.46 Million
Q4 2023

Feb 14, 2024

SELL
$19.54 - $28.66 $271,977 - $398,918
-13,919 Reduced 31.95%
29,644 $810,000
Q3 2023

Nov 14, 2023

BUY
$21.15 - $27.96 $591,607 - $782,097
27,972 Added 179.41%
43,563 $1.18 Million
Q2 2023

Aug 14, 2023

SELL
$11.16 - $23.65 $588,779 - $1.25 Million
-52,758 Reduced 77.19%
15,591 $351,000
Q1 2023

May 15, 2023

SELL
$10.12 - $14.91 $201,003 - $296,142
-19,862 Reduced 22.52%
68,349 $770,000
Q4 2022

Feb 14, 2023

BUY
$8.75 - $14.02 $269,858 - $432,390
30,841 Added 53.76%
88,211 $1.22 Million
Q3 2022

Nov 14, 2022

SELL
$7.46 - $19.28 $481,490 - $1.24 Million
-64,543 Reduced 52.94%
57,370 $633,000
Q2 2022

Aug 15, 2022

BUY
$15.06 - $30.65 $1.04 Million - $2.11 Million
69,004 Added 130.42%
121,913 $1.97 Million
Q1 2022

May 16, 2022

BUY
$23.26 - $42.41 $793,677 - $1.45 Million
34,122 Added 181.63%
52,909 $1.54 Million
Q4 2021

Feb 14, 2022

SELL
$37.54 - $57.51 $3.66 Million - $5.6 Million
-97,450 Reduced 83.84%
18,787 $796,000
Q3 2021

Nov 15, 2021

SELL
$45.91 - $59.67 $220,459 - $286,535
-4,802 Reduced 3.97%
116,237 $5.79 Million
Q2 2021

Aug 16, 2021

BUY
$43.3 - $67.17 $1.35 Million - $2.09 Million
31,176 Added 34.69%
121,039 $7.1 Million
Q1 2021

May 17, 2021

BUY
$44.11 - $90.64 $1.97 Million - $4.04 Million
44,566 Added 98.39%
89,863 $5.25 Million
Q4 2020

Feb 16, 2021

BUY
$33.89 - $49.88 $1.54 Million - $2.26 Million
45,297 New
45,297 $2.11 Million
Q2 2020

Aug 14, 2020

SELL
$19.21 - $28.53 $1.34 Million - $1.98 Million
-69,575 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$11.17 - $28.72 $33,811 - $86,935
-3,027 Reduced 4.17%
69,575 $1.28 Million
Q4 2019

Feb 14, 2020

SELL
$19.29 - $25.52 $482,520 - $638,357
-25,014 Reduced 25.62%
72,602 $1.72 Million
Q3 2019

Nov 14, 2019

SELL
$21.72 - $35.38 $196,370 - $319,870
-9,041 Reduced 8.48%
97,616 $2.14 Million
Q2 2019

Aug 14, 2019

BUY
$20.59 - $35.2 $2.02 Million - $3.45 Million
98,082 Added 1143.81%
106,657 $3.6 Million
Q1 2019

May 15, 2019

SELL
$17.28 - $25.83 $289,146 - $432,213
-16,733 Reduced 66.12%
8,575 $0
Q1 2018

May 11, 2018

BUY
$16.18 - $24.28 $409,483 - $614,478
25,308 New
25,308 $431,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $523M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.